Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol

American Journal of Psychiatry

Volumn 154, Issue 12, 1997, Pages 1763-1765

  Pollmächer, Thomas ^a   Hinze Selch, Dunja ^a   Fenzel, Thomas ^a   Kraus, Thomas ^a   Schuld, Andreas ^a   Mullington, Janet ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; CYTOKINE; CYTOKINE RECEPTOR; HALOPERIDOL; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; RECTUM TEMPERATURE; SCHIZOPHRENIA;

EID: 1842328036     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.12.1763     Document Type: Article

References (17)

1. Ganguli R, Barr JS, Chengappa KN, Yang ZW, Nimgaonkar VL, Rabin BS: Autoimmunity in schizophrenia: a review of recent findings. Ann Med 1993; 25:489-496
2. Yolken RH, Torrey EF: Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 1995; 8:131-145
3. Rubin LA, Nelson DL: The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 1990; 113:619-627
4. Diez-Ruis A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D: Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995; 54:1-8
5. Rothwell NJ, Hopkins SJ: Cytokines and the nervous system, II: actions and mechanisms of action. Trends Neurosci 1995; 18: 130-136
6. Bertini R, Garattini S, Delgado R, Ghezzi P: Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice. Immunology 1993; 79:217-219
7. Tarazona R, González-Garcia A, Zamzami N, Marchetti P, Frechin N, Gonzalo JA, Ruiz-Gayo M, van Rooijen N, Martinez AC, Kroemer G: Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo. J Immunol 1995; 154:861-870
8. Pollmächer T, Hinze-Selch D, Mullington J: Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol 1996; 16:403-409
9. Pollmächer T, Mullington J, Korth C, Hinze-Seich D: Influence of host defense activation on sleep in humans. Adv Neurpimmunol 1995; 5:155-169
10. Krueger JM, Takahashi S, Kapás L, Bredow S, Roky R, Fang J, Floyd R, Renegar KB, Guha-Thakurta N, Novitsky S, Obál F: Cytokines in sleep regulation. Adv Neuroimmunol 1995; 5:171-188
11. Hinze-Selch D, Mullington J, Orth A, Lauer CJ, Pollmächer T: Effects of clozapine on sleep - a longitudinal study. Biol Psychiatry 1997; 42:260-266
12. Hinze-Selch D, Mullington J, Pollmächer T: Sleep during cloza- pine-induced fever in a schizophrenic patient. Biol Psychiatry 1995; 38:690-693
13. Rapaport MH, Doran AR, Nelson DL, McAllister C, Magliozzi JR, Paul SM: Haloperidol and soluble interleukin-2 receptors (letter). Biol Psychiatry 1991; 30:1063-1064
14. Kim CE, Kang DY, Ha KS, Jeong SH, Kim YS: Haloperidol does not affect the level of serum-soluble interleukin-2 receptor in drug-free male schizophrenics. Biol Psychiatry 1995; 38:843-845
15. Pollmächer T, Hinze-Selch D, Mullington J, Holsboer F: Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors (letter). Arch Gen Psychiatry 1995; 52:877-878
16. Pollmächer T, Hinze-Selch D, Mullington J, Fenzel T, Holsboer F: Smoking affects plasma-soluble interleukin-2 receptor levels in patients with schizophrenia (letter). Arch Gen Psychiatry 1997; 54:89
17. Boyum A, Wiik P, Gustavsson E, Veiby OP, Reseland J, Haugen AH, Opstad PK: The effect of strenuous exercise, calorie deficiency and sleep deprivation on white blood cells, plasma immunoglobulins and cytokines. Scand J Immunol 1995; 43:228-235